A phase 1 open-label study to investigate the potential drug-drug interaction (DDI) between single-dose (SD) dacomitinib (PF-00299804; DC) and steady-state (SS) paroxetine (PX) in healthy volunteers (HVs)

被引：0
|
作者：
RuizaGarcia, Ana [1 ]
Giri, Nagdeep [1 ]
LaBadie, Robert R. [2 ]
Ni, Grace [3 ]
Boutros, Tanya [4 ]
Richie, Nicole [5 ]
Kocinsky, Hetal S. [6 ]
Bello, Carlo L. [7 ]
机构：
[1] Pfizer Oncol, La Jolla, CA USA
[2] Pfizer WRD, Groton, CT USA
[3] Pfizer Dev Operat, Groton, CT USA
[4] Pfizer Primary Care, La Jolla, CA USA
[5] Pfizer Cambridge, Cambridge, MA USA
[6] Pfizer Clin Res Unit, New Haven, CT USA
[7] Pfizer Clin Pharmacol, New York, NY USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-763
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
763
引用
收藏
页数：1
相关论文
共 15 条
  • [1] A Phase I Open-Label Study to Investigate the Potential Drug-Drug Interaction Between Single-Dose Dacomitinib and Steady- State Paroxetine in Healthy Volunteers
    Ruiz-Garcia, Ana
    Giri, Nagdeep
    LaBadie, Robert R.
    Ni, Grace
    Boutros, Tanya
    Richie, Nicole
    Kocinsky, Hetal S.
    Checchio, Tina M.
    Bello, Carlo L.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (05): : 555 - 562
  • [2] Open-Label, Single-Dose, Parallel-Group Study in Healthy Volunteers To Determine the Drug-Drug Interaction Potential between KAE609 (Cipargamin) and Piperaquine
    Stein, Daniel S.
    Jain, Jay Prakash
    Kangas, Michael
    Lefevre, Gilbert
    Machineni, Surendra
    Griffin, Paul
    Lickliter, Jason
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (06) : 3493 - 3500
  • [3] A Phase 1, Single-Dose, Open-Label Pharmacokinetic Study to Investigate the Drug-Drug Interaction Potential of ZX008 (Fenfluramine HCl Oral Solution) and Cannabidiol
    Boyd, B.
    Smith, S.
    Farfel, G.
    Morrison, G.
    ANNALS OF NEUROLOGY, 2019, 86 : S57 - S58
  • [4] A Two-Period Open-Label, Single-Dose Crossover Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Between Cimetidine and Inhaled Extrafine CHF 5993
    Mariotti, Fabrizia
    Ciurlia, Giorgia
    Spaccapelo, Luca
    Muraro, Annamaria
    Acerbi, Daniela
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (02) : 269 - 279
  • [5] A Phase 1, Open-Label, Fixed-Sequence, Drug-Drug Interaction Study of Zanubrutinib with Rifabutin in Healthy Volunteers
    Tariq, Bilal
    Conto, Stephanie
    Cohen, Aileen
    Sahasranaman, Srikumar
    Ou, Ying. C. C.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (08): : 832 - 838
  • [6] Effect of Multiple Doses of Sparsentan on the Single-Dose Pharmacokinetics of Dapagliflozin: An Open-Label Drug-Drug Interaction Study in Healthy Adults
    Chen, Shang-Chiung
    Cai, Danlin
    Winnett, Claire
    Nguyen, Mai
    Verma, Neeraj
    Liu, Kai
    Preciado, Priscila
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (05): : 535 - 541
  • [7] Effect of Multiple Doses of Sparsentan on the Single-Dose Pharmacokinetics of Dapagliflozin: Open-Label Drug-Drug Interaction Study in Healthy Adults
    Chen, Charles
    Cai, Danlin
    Winnett, Claire E.
    Verma, Neeraj
    Preciado, Priscila
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 385 - 385
  • [8] A PHASE 1 DRUG-DRUG INTERACTION STUDY ASSESSING THE EFFECTS OF STEADY STATE (SS) PROBENECID (PB) ON SINGLE-DOSE BEMPEDOIC ACID (BA) PHARMACOKINETICS (PK) IN HEALTHY SUBJECTS.
    Emery, M.
    Hanselman, J.
    MacDougall, D.
    Amore, B.
    Sasiela, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S43 - S43
  • [9] A Two-Period Open-Label, Single-Dose Crossover Study in Healthy Volunteers to Evaluate the Drug–Drug Interaction Between Cimetidine and Inhaled Extrafine CHF 5993
    Fabrizia Mariotti
    Giorgia Ciurlia
    Luca Spaccapelo
    Annamaria Muraro
    Daniela Acerbi
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 269 - 279
  • [10] A phase I, single-sequence, open-label study to evaluate the drug-drug interaction between hetrombopag and cyclosporine in healthy Chinese subjects
    Li, Fengshan
    Lin, Hongda
    Feng, Shiyin
    Cai, Linrui
    Zhang, Lingli
    Feng, Sheng
    Liu, Xiaohong
    Chen, Zhuo
    Zou, Qin
    Wu, Yiwen
    Su, Xu
    Shen, Kai
    Yu, Qin
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (07) : 2160 - 2167
12